Adults with differentiated thyroid cancer who are using a GLP-1 for the treatment of diabetes or obesity do not have increased risk for cancer recurrence or progression vs. those not using a GLP-1, ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

Researchers at the Johns Hopkins Kimmel Cancer Center have discovered how certain pathogenic bacteria in gut and breast ...

Metastasis-directed therapy for oligometastatic prostate cancer was associated with improved outcomes in a systematic review and meta-analysis.

Molecular ESR1 changes may signal symptomatic progression before imaging in metastatic breast cancer, supporting camizestrant for improved quality of life. It's consistent with the idea that it is a ...

Women with stage IV breast cancer detected through screening have a 60% chance of survival ten years after diagnosis. This is in comparison to a survival rate of under 20% of those with stage IV ...

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

University Hospital Southampton is leading a study where researchers will see if a diagnostic tampon can help spot the early ...